Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Performance Evaluation Study of DragonFly M2 System for Mitral Regurgitation

NCT07243197 is registered in ClinicalTrials.gov with Hangzhou Valgen Medtech Co., Ltd as lead sponsor.

NCT NCT07243197
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07243197 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Performance Evaluation Study of DragonFly M2 System for Mitral Regurgitation
Lead sponsor
Hangzhou Valgen Medtech Co., Ltd
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 15, 2026
Completion date
June 30, 2031
Enrollment
53 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mitral valve (mv) regurgitation